Spanish pharmaceutical company secures DOJ declination

The Justice Department has closed its investigation into possible Foreign Corrupt Practices Act violations at a Spanish pharmaceutical company that was commended for its full cooperation with the probe.

Get unlimited access to all Global Investigations Review content